Trends in Conventional Heart Failure Therapy in a Real-World Multinational ATTR-CA Cohort

Background: Conventional HF treatment in transthyretin cardiac amyloidosis (ATTR-CA) resulting in restrictive cardiomyopathy is debated due to absent trial evidence in this specific sub-population of heart failure (HF) patients. Current European Society of Cardiology guidelines recommend the use of...

詳細記述

書誌詳細

主要な著者:	Eva H. van der Geest, Nina Ajmone Marsan, Dorien Laenens, Philippe J. M. R. Debonnaire, Mathias Claeys, Fauto Pinto, Dulce Brito, Erwan Donal, Steven Droogmans, Nico Van de Veire, Philippe Bertrand, Takeru Nabeta, Francesca Graziani, Madelien V. Regeer
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-10-01
シリーズ:	Journal of Cardiovascular Development and Disease
主題:	transthyretin cardiac amyloidosis heart failure medication beta-blockers angiotensin-converting enzyme inhibitors angiotensin II receptor blockers
オンライン･アクセス:	https://www.mdpi.com/2308-3425/12/10/403
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!